Edition:
United Kingdom

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

1.36USD
15 Dec 2017
Change (% chg)

$0.03 (+2.26%)
Prev Close
$1.33
Open
$1.36
Day's High
$1.41
Day's Low
$1.35
Volume
47,836
Avg. Vol
129,887
52-wk High
$30.40
52-wk Low
$1.24

Latest Key Developments (Source: Significant Developments)

Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - Reshape Lifesciences Inc ::RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​.  Full Article

Reshape Lifesciences qtrly loss per share $1.06‍​
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Reshape Lifesciences Inc ::Reshape Lifesciences announces third quarter 2017 financial results.Q3 revenue $360,000.Reshape Lifesciences Inc - qtrly loss per share $1.06‍​.  Full Article

CVI Investments Inc reports 9.9 pct passive stake in Enteromedics Inc
Friday, 26 Aug 2016 

: CVI Investments Inc reports 9.9 pct passive stake in enteromedics inc, as of August 18, 2016 - Sec Filing Source - http://bit.ly/2cetnP4 Further company coverage: [ETRM.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Enteromedics Q2 loss per share $0.49
Thursday, 4 Aug 2016 

Enteromedics Inc : Enteromedics reports second quarter 2016 financial results . Q2 loss per share $0.49 .Q2 sales $276,000.  Full Article

EnteroMedics says CFP Greg Lea to retire effective as of October 1, 2016
Wednesday, 6 Jul 2016 

Enteromedics Inc :On june 30, greg lea, co's cfo said intends to retire and leave his position with company effective as of october 1, 2016 - sec filing.  Full Article

BRIEF-Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​

* RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)